Bios Equity COF, LP

Bios Equity COF, LP is listed in filings as Director, 10% Owner at Actuate Therapeutics Inc. This profile follows SEC Form 4 activity through Jun 30, 2025, including purchase activity. Recent filings connect the profile to Actuate Therapeutics Inc (ACTU). The current snapshot covers public activity from Jun 30, 2025. Reported amounts are shown as $500.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.